METTL14 and familial pancreatic carcinoma: In the present study, we demonstrate that the expression of METTL14 was increased after gemcitabine treatment, and METTL14, but not other m6A associated proteins, was overexpressed in the gemcitabine resistant pancreatic cancer cell lines.